GBS is a reported autoimmune demyelination disease affecting both the central nervous system (CNS) and PNS [33], meanwhile, our data of the elevated IL-17 and IL-22 levels in CSF and plasma of GBS confirmed this respect. Here, IL17A is linked to Guillain-Barre syndrome.